Paul Tudor Jones Grifols Sa Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$15.4 - $20.16 $226,380 - $296,352
-14,700 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$18.24 - $21.45 $43,538 - $51,201
2,387 Added 19.39%
14,700 $268,000
Q1 2020

May 15, 2020
BUY
$16.28 - $25.63 $200,455 - $315,582
12,313 New
12,313 $248,000

Others Institutions Holding GRFS

# of Institutions
164
Shares Held
140M
Call Options Held
288K
Put Options Held
389K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.75B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email